Transforming Cancer Care with Radiopharmaceutical Innovation

We are developing next-generation targeted therapies for
treatment-resistant cancer.

We are developing next-generation targeted therapies for
treatment-resistant cancer.

Transforming
Cancer Care with Radiopharmaceutical Innovation

We are developing next-generation targeted therapies for
treatment-resistant cancer.

Launch Announcement

Nuclide Therapeutics secures £5 million
investment to spearhead the clinical development of our lead therapeutic, [131I]NTx-11.

Nuclide Therapeutics secures £5 million
investment to spearhead the clinical development of our lead therapeutic, [131I]NTx-11.

Nuclide Therapeutics secures £5 million
investment to spearhead the clinical development of our lead therapeutic, [131I]NTx-11.

Our Mission

Nuclide Therapeutics is pioneering radiopharmaceutical therapies that unite nuclear medicine with biotechnology to target novel cancer biomarkers. Our mission is to provide hope and new treatment options for patients with cancers that have limited alternatives.

Press Release

Read our press release detailing the conclusion of our recent funding round.

The Founders

Bringing together experts in radiopharmaceutical development.

Muhammet Tanç, PhD

Photo of Muhammet Tanç, PhD
Photo of Muhammet Tanç, PhD

Muhammet Tanç, PhD

Photo of Muhammet Tanç, PhD
Photo of Muhammet Tanç, PhD

Muhammet Tanç, PhD

Photo of Muhammet Tanç, PhD
Photo of Muhammet Tanç, PhD

Tim Witney, PhD

Photo of Tim Witney
Photo of Tim Witney

Tim Witney, PhD

Photo of Tim Witney
Photo of Tim Witney

Tim Witney, PhD

Photo of Tim Witney
Photo of Tim Witney

Sofia Santos, PhD

Photo of Sofia Santos, PhD
Photo of Sofia Santos, PhD

Sofia Santos, PhD

Photo of Sofia Santos, PhD
Photo of Sofia Santos, PhD

Sofia Santos, PhD

Photo of Sofia Santos, PhD
Photo of Sofia Santos, PhD

Richard Edwards, PhD

Photo of Richard Edwards, PhD
Photo of Richard Edwards, PhD

Richard Edwards, PhD

Photo of Richard Edwards, PhD
Photo of Richard Edwards, PhD

Richard Edwards, PhD

Photo of Richard Edwards, PhD
Photo of Richard Edwards, PhD

Stay Connected

Sign up. We’ll keep you updated on our clinical trial and pipeline development.

© 2025 Nuclide Therapeutics, All rights reserved

© 2025 Nuclide Therapeutics, All rights reserved

© 2025 Nuclide Therapeutics, All rights reserved